Ribosome distribution key to programming cells – Lab News
Lab News |
Ribosome distribution key to programming cells
Lab News Declan Bates, Professor of Bioengineering at the University of Warwick’s School of Engineering and Co-Director, Warwick Integrative Synthetic Biology Centre (WISB) said: “Synthetic Biology is about making cells easier to engineer so that we can address … |
|
American CryoStem Enters Into Agreement to License its Patented Adipose Tissue and Stem Cell Technologies in …
GlobeNewswire (press release) American CryoStem has licensed to Cryoviva (Thailand) Ltd., established in 2007, the rights to utilize the Company’s Standard Operating Procedures (SOP’s) to create and market the Company’s ATGRAFT™ tissue storage service and ATCELL™ adipose derived … |
In-PharmaTechnologist.com |
Lilly to develop encapsulated diabetes cell therapies through Sigilon deal
In-PharmaTechnologist.com Eli Lilly has licensed Sigilon Therapeutics’ technology to develop encapsulated cell therapies for the treatment of type 1 diabetes. Under the terms, Sigilon will use its Afibromer platform to ‘encapsulate’ – the process of immobilising cells with a … Lilly researches cell therapies for type 1 diabetes with Sigilonpharmaphorum Lilly and Sigilon partner to develop diabetes type I therapiesPharmaTimes |
|
Gene Therapy Advances: What Health Execs Should Know
ModernMedicine Although only three gene therapies have been approved in the United States—all in 2017—these innovative treatments are leaving their imprint on the healthcare system. Novartis’ Kymriah (tisagenlecleucel), a chimeric antigen receptor (CAR)T-cell … |